首页> 外文期刊>Journal of minimal access surgery >Short- and long-term outcomes of laparoscopic-assisted surgery, mini-laparotomy and conventional laparotomy in patients with Stage I-III colorectal cancer
【24h】

Short- and long-term outcomes of laparoscopic-assisted surgery, mini-laparotomy and conventional laparotomy in patients with Stage I-III colorectal cancer

机译:I-III期结直肠癌患者的腹腔镜辅助手术,小型腹腔镜开腹术和常规剖腹术的短期和长期结果

获取原文
           

摘要

Background: Three operative techniques have been used for colorectal cancer (CRC) resection: Conventional laparotomy (CL) and the mini-invasive techniques (MITs)– laparoscopic-assisted surgery (LAS) and mini-laparotomy (ML). The aim of the study was to compare the short- and long-term outcomes of patients undergoing the three surgical approaches for Stage I–III CRC resection. Patients and Methods: This study enrolled 688 patients with Stage I–III CRC undergoing curative resection. The primary endpoints were perioperative quality and outcomes. The secondary endpoints were oncological outcomes including disease-free survival (DFS), overall survival (OS) and local recurrence (LR). Results: Patients undergoing LAS had significantly less blood loss (P P = 0.002) and earlier resumption of normal diet (P = 0.025). Although post-operative complication rates were remarkably higher in patients undergoing CL than in those undergoing MITs (P = 0.002), no difference was observed in the post-operative mortality rate (P = 0.099) or 60-day re-intervention rate (P = 0.062). The quality of operation as assessed by the number of lymph nodes harvested and rates of R0 resection did not differ among the groups (all P > 0.05). During a median follow-up of 5.42 years, no significant difference was observed among the treatment groups in the rates of 3-year late morbidity, 3-year LR, 5-year LR, 5-year OS or 5-year DFS (all P > 0.05). Conclusions: Patients undergoing CL had higher post-operative morbidities. Moreover, the study findings confirm the favourable short-term and comparable long-term outcomes of LAS and ML for curative CRC resection. Therefore, both MITs may be feasible and safe alternatives to CL for Stage I-III CRC resection.
机译:背景:三种手术技术已用于结直肠癌(CRC)切除术:常规剖腹术(CL)和微创技术(MITs)–腹腔镜辅助手术(LAS)和微腹腔镜手术(ML)。该研究的目的是比较接受I-III期CRC切除的三种手术方法的患者的短期和长期结局。患者和方法:本研究招募了688例行根治性切除术的CRC患者。主要终点是围手术期质量和预后。次要终点是肿瘤学结局,包括无病生存期(DFS),总体生存期(OS)和局部复发(LR)。结果:接受LAS治疗的患者失血量明显减少(P P = 0.002),恢复正常饮食的时间更早(P = 0.025)。尽管接受CL的患者的术后并发症发生率明显高于接受MIT的患者(P = 0.002),但术后死亡率(P = 0.099)或60天再次干预率(P = 0.062)。各组之间通过收集的淋巴结数目和R0切除率评估的手术质量无差异(所有P> 0.05)。在5.42年的中位随访期间,各治疗组之间的3年晚期发病率,3年LR,5年LR,5年OS或5年DFS的发生率没有显着差异(所有P> 0.05)。结论:CL患者术后并发症发生率较高。此外,研究结果证实了LAS和ML对于根治性CRC切除具有有利的短期和相当的长期结果。因此,对于I-III期CRC切除,两个MIT可能都是CL的可行且安全的替代方案。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号